Take a fresh look at your lifestyle.
Live Updates COVID-19 CASES
  • World 18,691,690
    World
    Confirmed: 18,691,690
    Active: 6,079,058
    Recovered: 11,909,258
    Death: 703,374
  • USA 4,918,416
    USA
    Confirmed: 4,918,416
    Active: 2,276,508
    Recovered: 2,481,618
    Death: 160,290
  • South Africa 521,318
    South Africa
    Confirmed: 521,318
    Active: 148,683
    Recovered: 363,751
    Death: 8,884
  • Nigeria 44,433
    Nigeria
    Confirmed: 44,433
    Active: 11,672
    Recovered: 31,851
    Death: 910
  • Kenya 23,202
    Kenya
    Confirmed: 23,202
    Active: 13,487
    Recovered: 9,327
    Death: 388
  • Australia 18,730
    Australia
    Confirmed: 18,730
    Active: 7,876
    Recovered: 10,622
    Death: 232
  • South Sudan 2,437
    South Sudan
    Confirmed: 2,437
    Active: 1,215
    Recovered: 1,175
    Death: 47
  • Uganda 1,203
    Uganda
    Confirmed: 1,203
    Active: 125
    Recovered: 1,073
    Death: 5

Hope as Kenya to try Covid-19 drug on patients

296

Kenya will start testing the only-approved Covid-19 drug on patients in the coming days.

The drug, known as remdesivir, costs Sh253,000 per treatment.

Dr Loice Achieng Ombajo, the head of infectious diseases unit at Kenyatta National Hospital (KNH), said a World Health Organisation (WHO) sponsored study on remdesivir will not be testing chloroquine, or the HIV drugs – lopinavir and ritonavir – as had been proposed earlier.




Dr Achieng, the study principal investigator, was addressing doctors from all over the country in a webinar organised by KNH to share experiences in treating Covid-19 patients.

The study, approved earlier this month, will be carried out at the Coast General Hospital, KNH, Aga Khan University Hospital, Nairobi Hospital, Kilifi Kemri-Wellcome, Moi Teaching and Referral Hospital, and Kenyatta University Hospital.




Remdesivir, an injectable manufactured by the Gilead Sciences of United States, is the only drug authorised for treatment of Covid-19 patients by the US Food and Drug Administration and European Medicines Agency. Initially, the drug had been developed for the treatment of Ebola.

Preliminary data from various clinical studies have shown the drug to reduce hospitalisation period in some Covid-19 patients by about four days.




In the US, the manufacturer has tagged the price of remdesivir, which is in short supply, at $2,340 (about Sh 253,000) for a full treatment.

Read the Original Article on The Standard

CORONAVIRUS CASES

Live Updates COVID-19 CASES
  • World 18,691,686
    World
    Confirmed: 18,691,686
    Active: 6,079,116
    Recovered: 11,909,196
    Death: 703,374
  • USA 4,918,416
    USA
    Confirmed: 4,918,416
    Active: 2,276,508
    Recovered: 2,481,618
    Death: 160,290
  • South Africa 521,318
    South Africa
    Confirmed: 521,318
    Active: 148,683
    Recovered: 363,751
    Death: 8,884
  • Nigeria 44,433
    Nigeria
    Confirmed: 44,433
    Active: 11,672
    Recovered: 31,851
    Death: 910
  • Kenya 23,202
    Kenya
    Confirmed: 23,202
    Active: 13,487
    Recovered: 9,327
    Death: 388
  • Australia 18,730
    Australia
    Confirmed: 18,730
    Active: 7,876
    Recovered: 10,622
    Death: 232
  • South Sudan 2,437
    South Sudan
    Confirmed: 2,437
    Active: 1,215
    Recovered: 1,175
    Death: 47
  • Uganda 1,203
    Uganda
    Confirmed: 1,203
    Active: 125
    Recovered: 1,073
    Death: 5
Comments